IL87973A - Implantable biodegradable system for releasing active substance and its preparation - Google Patents

Implantable biodegradable system for releasing active substance and its preparation

Info

Publication number
IL87973A
IL87973A IL87973A IL8797388A IL87973A IL 87973 A IL87973 A IL 87973A IL 87973 A IL87973 A IL 87973A IL 8797388 A IL8797388 A IL 8797388A IL 87973 A IL87973 A IL 87973A
Authority
IL
Israel
Prior art keywords
preparation
active substance
releasing active
implantable biodegradable
biodegradable system
Prior art date
Application number
IL87973A
Other languages
English (en)
Other versions
IL87973A0 (en
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of IL87973A0 publication Critical patent/IL87973A0/xx
Publication of IL87973A publication Critical patent/IL87973A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
IL87973A 1987-10-09 1988-10-07 Implantable biodegradable system for releasing active substance and its preparation IL87973A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873734223 DE3734223A1 (de) 1987-10-09 1987-10-09 Implantierbares, biologisch abbaubares wirkstofffreigabesystem

Publications (2)

Publication Number Publication Date
IL87973A0 IL87973A0 (en) 1989-03-31
IL87973A true IL87973A (en) 1992-08-18

Family

ID=6338006

Family Applications (1)

Application Number Title Priority Date Filing Date
IL87973A IL87973A (en) 1987-10-09 1988-10-07 Implantable biodegradable system for releasing active substance and its preparation

Country Status (17)

Country Link
EP (1) EP0311065B1 (fr)
JP (1) JP2763303B2 (fr)
KR (1) KR970006082B1 (fr)
AT (1) ATE101035T1 (fr)
AU (1) AU609194B2 (fr)
CA (1) CA1333770C (fr)
DE (2) DE3734223A1 (fr)
DK (1) DK175252B1 (fr)
ES (1) ES2061589T3 (fr)
FI (1) FI100302B (fr)
IE (1) IE62505B1 (fr)
IL (1) IL87973A (fr)
NO (1) NO176304C (fr)
NZ (1) NZ226514A (fr)
PH (1) PH30236A (fr)
PT (1) PT88703B (fr)
ZA (1) ZA887535B (fr)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2209937B (en) * 1987-09-21 1991-07-03 Depiopharm S A Water insoluble polypeptides
US5216050A (en) * 1988-08-08 1993-06-01 Biopak Technology, Ltd. Blends of polyactic acid
US5180765A (en) * 1988-08-08 1993-01-19 Biopak Technology, Ltd. Biodegradable packaging thermoplastics from lactides
US5424346A (en) * 1988-08-08 1995-06-13 Ecopol, Llc Biodegradable replacement of crystal polystyrene
US5444113A (en) * 1988-08-08 1995-08-22 Ecopol, Llc End use applications of biodegradable polymers
US6323307B1 (en) 1988-08-08 2001-11-27 Cargill Dow Polymers, Llc Degradation control of environmentally degradable disposable materials
US5252642A (en) * 1989-03-01 1993-10-12 Biopak Technology, Ltd. Degradable impact modified polyactic acid
US5702716A (en) * 1988-10-03 1997-12-30 Atrix Laboratories, Inc. Polymeric compositions useful as controlled release implants
CA2056384C (fr) * 1989-06-05 1998-06-23 Tobin N. Gerhart Polymeres bioerodables pour la liberation de medicaments dans les os
US5487897A (en) * 1989-07-24 1996-01-30 Atrix Laboratories, Inc. Biodegradable implant precursor
US5439688A (en) * 1989-07-28 1995-08-08 Debio Recherche Pharmaceutique S.A. Process for preparing a pharmaceutical composition
CH679207A5 (fr) * 1989-07-28 1992-01-15 Debiopharm Sa
DE69101313T2 (de) * 1990-01-30 1994-06-30 Akzo Nv Gegenstand zur gesteuerten wirkstoffabgabe mit einem von einer wand völlig umschlossenen hohlraum und völlig oder teilweise mit einem oder mehreren wirkstoffen gefüllt.
DE69004415D1 (de) * 1990-03-05 1993-12-09 Minnesota Mining & Mfg Vorrichtung zur verzögerten Abgabe von pharmakologisch aktiven Verbindungen ins Ohr.
US5350580A (en) * 1990-03-05 1994-09-27 Minnesota Mining And Manufacturing Company Device and method for extended delivery of pharmacologically active agents to the ear
AU2605592A (en) * 1991-10-15 1993-04-22 Atrix Laboratories, Inc. Polymeric compositions useful as controlled release implants
US5681873A (en) * 1993-10-14 1997-10-28 Atrix Laboratories, Inc. Biodegradable polymeric composition
US5605696A (en) * 1995-03-30 1997-02-25 Advanced Cardiovascular Systems, Inc. Drug loaded polymeric material and method of manufacture
US5869079A (en) 1995-06-02 1999-02-09 Oculex Pharmaceuticals, Inc. Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
AU6491898A (en) * 1997-04-04 1998-10-30 Alcan International Limited Aluminum alloy composition and method of manufacture
MY118835A (en) * 1997-04-18 2005-01-31 Ipsen Pharma Biotech Sustained release compositions and the process for their preparation
US6261583B1 (en) 1998-07-28 2001-07-17 Atrix Laboratories, Inc. Moldable solid delivery system
US6143314A (en) * 1998-10-28 2000-11-07 Atrix Laboratories, Inc. Controlled release liquid delivery compositions with low initial drug burst
DE19908753C2 (de) * 1999-02-20 2003-10-02 Jenapharm Gmbh Bioabbaubare, injizierbare Oligomer-Polymer-Zusammensetzung
US6306425B1 (en) * 1999-04-09 2001-10-23 Southern Research Institute Injectable naltrexone microsphere compositions and their use in reducing consumption of heroin and alcohol
US8226598B2 (en) 1999-09-24 2012-07-24 Tolmar Therapeutics, Inc. Coupling syringe system and methods for obtaining a mixed composition
US6702849B1 (en) 1999-12-13 2004-03-09 Advanced Cardiovascular Systems, Inc. Method of processing open-celled microcellular polymeric foams with controlled porosity for use as vascular grafts and stent covers
DE60132525T2 (de) 2000-03-22 2009-01-29 Dainippon Ink And Chemicals, Inc. Schlagzäh-modifizierer und diese modifizierer enthaltende polyesterzusammensetzung
US6726918B1 (en) 2000-07-05 2004-04-27 Oculex Pharmaceuticals, Inc. Methods for treating inflammation-mediated conditions of the eye
EP3167872B1 (fr) * 2000-07-05 2020-10-14 Allergan, Inc. Procédés de traitement des états inflammatoires de l' oeil
AU3649502A (en) 2000-11-29 2002-06-11 Oculex Pharm Inc Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor
US20050048099A1 (en) 2003-01-09 2005-03-03 Allergan, Inc. Ocular implant made by a double extrusion process
US20070224278A1 (en) 2003-11-12 2007-09-27 Lyons Robert T Low immunogenicity corticosteroid compositions
US20050101582A1 (en) 2003-11-12 2005-05-12 Allergan, Inc. Compositions and methods for treating a posterior segment of an eye
CA2553381C (fr) 2004-01-20 2011-03-22 Allergan, Inc. Compositions pour traitement local de l'oeil, comprenant de preference de l'acetonide de triamcinolone et de l'acide hyaluronique
US8591885B2 (en) 2004-04-30 2013-11-26 Allergan, Inc. Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems
US7799336B2 (en) 2004-04-30 2010-09-21 Allergan, Inc. Hypotensive lipid-containing biodegradable intraocular implants and related methods
US8673341B2 (en) 2004-04-30 2014-03-18 Allergan, Inc. Intraocular pressure reduction with intracameral bimatoprost implants
BRPI0510485A (pt) 2004-04-30 2007-11-13 Allergan Inc implantes inibidores de tirosina cinase intravìtreos biodegradáveis
US8425929B2 (en) 2004-04-30 2013-04-23 Allergan, Inc. Sustained release intraocular implants and methods for preventing retinal dysfunction
US7993634B2 (en) 2004-04-30 2011-08-09 Allergan, Inc. Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
US8119154B2 (en) 2004-04-30 2012-02-21 Allergan, Inc. Sustained release intraocular implants and related methods
US20050244469A1 (en) 2004-04-30 2005-11-03 Allergan, Inc. Extended therapeutic effect ocular implant treatments
US20050244463A1 (en) 2004-04-30 2005-11-03 Allergan, Inc. Sustained release intraocular implants and methods for treating ocular vasculopathies
US9498457B2 (en) 2004-04-30 2016-11-22 Allergan, Inc. Hypotensive prostamide-containing biodegradable intraocular implants and related implants
US8147865B2 (en) 2004-04-30 2012-04-03 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
US20050244458A1 (en) 2004-04-30 2005-11-03 Allergan, Inc. Sustained release intraocular implants and methods for treating ocular neuropathies
US8722097B2 (en) 2004-04-30 2014-05-13 Allergan, Inc. Oil-in-water method for making polymeric implants containing a hypotensive lipid
US7771742B2 (en) 2004-04-30 2010-08-10 Allergan, Inc. Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
US8475829B2 (en) * 2006-04-06 2013-07-02 Nupathe Inc. Implants for the treatment of dopamine associated states
US8802128B2 (en) 2006-06-23 2014-08-12 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
US8969415B2 (en) 2006-12-01 2015-03-03 Allergan, Inc. Intraocular drug delivery systems
US8889173B2 (en) * 2008-04-18 2014-11-18 Warsaw Orthopedic, Inc. Alpha adrenergic receptor agonists for treatment of pain and/or inflammation
US8956641B2 (en) * 2008-04-18 2015-02-17 Warsaw Orthopedic, Inc. Alpha adrenergic receptor agonists for treatment of inflammatory diseases
US10588855B2 (en) 2008-05-12 2020-03-17 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
US9877973B2 (en) 2008-05-12 2018-01-30 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
JP5982287B2 (ja) 2009-11-09 2016-08-31 アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ 発毛を刺激する組成物および方法
JP4779169B1 (ja) * 2010-10-27 2011-09-28 Ｎｅｃインフロンティア株式会社 ボタン照明構造、電子機器
RU2641021C2 (ru) 2013-02-15 2018-01-17 Аллерган, Инк. Имплантат для пролонгированной доставки лекарственного средства
GB201505527D0 (en) 2015-03-31 2015-05-13 Jmedtech Pte Ltd Composition
CA3078555A1 (fr) 2017-10-06 2019-04-11 Foundry Therapeutics, Inc. Depots implantabes pour la liberation controlee d'agents therapeutiques

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL109293C (fr) * 1955-12-22
US3755558A (en) * 1971-02-23 1973-08-28 Du Pont Polylactide drug mixtures for topical application atelet aggregation
DE3218150C2 (de) * 1982-05-14 1986-09-25 Akzo Gmbh, 5600 Wuppertal Wirkstoff enthaltender Körper für die Langzeitabgabe sowie Verfahren zu dessen Herstellung
US4962091A (en) * 1986-05-23 1990-10-09 Syntex (U.S.A.) Inc. Controlled release of macromolecular polypeptides
US4758435A (en) * 1986-08-11 1988-07-19 American Cyanamid Company Estradiol implant composition and method for preparation
DE3710175A1 (de) * 1987-02-12 1988-08-25 Hoechst Ag Mehrteilige implantierbare arzneizubereitung mit langzeitwirkung

Also Published As

Publication number Publication date
PH30236A (en) 1997-02-05
EP0311065B1 (fr) 1994-02-02
KR890006222A (ko) 1989-06-12
PT88703B (pt) 1992-12-31
DK561588D0 (da) 1988-10-07
EP0311065A1 (fr) 1989-04-12
DE3734223A1 (de) 1989-04-20
NO884474D0 (no) 1988-10-07
FI884604A0 (fi) 1988-10-07
DE3887616D1 (de) 1994-03-17
DK561588A (da) 1989-04-10
FI884604A (fi) 1989-04-10
NO884474L (no) 1989-04-10
IE883040L (en) 1989-04-09
NO176304C (no) 1995-03-22
CA1333770C (fr) 1995-01-03
NZ226514A (en) 1990-02-26
AU609194B2 (en) 1991-04-26
JP2763303B2 (ja) 1998-06-11
IE62505B1 (en) 1995-02-08
PT88703A (pt) 1988-11-01
ES2061589T3 (es) 1994-12-16
JPH02117A (ja) 1990-01-05
FI100302B (fi) 1997-11-14
ZA887535B (en) 1990-06-27
AU2352288A (en) 1989-04-13
IL87973A0 (en) 1989-03-31
KR970006082B1 (ko) 1997-04-23
NO176304B (no) 1994-12-05
ATE101035T1 (de) 1994-02-15
DK175252B1 (da) 2004-07-19

Similar Documents

Publication Publication Date Title
IL87973A0 (en) Implantable biodegradable system for releasing active substance and its preparation
NZ221390A (en) Biodegradable implant containing estradiol and poly(lactide-co-glycolide) polymer: method of administration and preparation
HK1040631A1 (en) Pharmaceutical compositions based on alpha-cyclodextrin for the oral administration of lh-rh analogues.
AU1099288A (en) Drug delivery system and method of making the same
ATE361093T1 (de) Selektiv auf die leber wirkende pharmazeutisch aktive substanz
NZ216082A (en) Prolonged-release microparticles
EP0211601A3 (fr) Stabilisation d'hormones de croissance
CA2024505A1 (fr) Forme posologique pour l'administration de medicaments solubles ou insolubles
DK305087A (da) Buprenorphinholdigt farmaceutisk suppositorium
ATE94764T1 (de) Nasal applizierbares arzneimittel, verfahren zu seiner herstellung und seine verwendung.
EP0380989A3 (en) Plaster for transdermal administration
IL85144A (en) Controlled release oral pharmaceutical compositions containing cyclic carboxylic acid esters or their polymers as carrier or coating material and their preparation
EP0649660A3 (fr) Compositions pharmaceutiques pour l'administration parentérale, entérale et dermale d'agents actifs pratiquement insolubles, et procédé pour leur fabrication.
GR1000266B (el) Μεθοδος παρασκευης μιας συνθεσης βασισμενης σε πολυεστερα για την ελεγχομενη εκλυση φαρμακευτικων ουσιων.
TW221692B (fr)
Laczay More important drug side-effects and interactions in the veterinary medicine. I. Antibacterial drugs. Review article.
IT8723007A0 (it) Composizioni farmaceutiche per uso orale ad attivita' sequestrante degli acidi biliari contenenti colestiramina quale principio attivo, e procedimento per prepararle
FR2640625B2 (fr) Nouveaux composes optiquement actifs derives de l'indane, leur application comme medicaments et les compositions pharmaceutiques les renfermant

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXTN Extension order renewed